Fund+ is a Belgian venture capital firm based in Leuven that invests in innovative European Life Sciences companies, primarily in therapeutics, diagnostics, and medical devices. It is an open-ended fund for long-term equity investment with a focus on Belgium, targeting companies at Series A or B stage that have reached proof of concept.
58% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $42.8M (across 6 rounds with reported amounts).
Portfolio
27
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
40 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Tubulis | Series C | — | Oct 2025 |
| TTubulis GmbH | Series C | — | Oct 2025 |
 Hirundo | Seed | $8M | Jun 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
 Coave Therapeutics | Series A | $32M | Jan 2025 |
 Confo Therapeutics | Series B | — | Jan 2024 |
 eTheRNA immunotherapies | Unknown | — | Aug 2022 |
 eTheRNA | Unknown | — | Aug 2022 |
| Tubulis | Series B | — | May 2022 |
| TTubulis GmbH | Series B | — | May 2022 |
 TargED Biopharmaceuticals B.V. | Series A | — | Feb 2022 |
| TTarged Biopharmaceuticals | Series A | — | Jan 2022 |
| TTubulis GmbH | Series B | — | Jan 2022 |
| TargED Biopharmaceuticals B.V. | Series A | — | Jan 2022 |
 Novadip Biosciences | Series B | — | Jan 2022 |
 EYED PHARMA | Unknown | — | Dec 2021 |
 Egle Therapeutics | Series A | — | Oct 2021 |
 Cardior | Series B | — | Aug 2021 |
| Coave Therapeutics | Series B | — | Jul 2021 |
 EXEVIR BIO | Series A | — | Mar 2021 |
 Timee, Inc. | Series D | — | Jan 2021 |
| EExeVir | Series A | — | Jan 2021 |
 Filtered | Seed | $7M | Jan 2021 |
| IIndigo Diabetes | Series B | — | Jul 2020 |
| IIndigo Diabetes | Series A | — | Jul 2020 |
Page 1 of 2
Top Co-Investors
Andera Partners8 shared
High-Tech Gründerfonds7 shared
PMV7 shared
Bpifrance6 shared
Kurma Partners6 shared
coparion6 shared
Bayern Kapital5 shared
Seventure Partners5 shared
INKEF Capital5 shared
Hadean Ventures5 shared
Ysios Capital5 shared
LSP5 shared
Wellington Management4 shared
Sunstone Life Science Ventures4 shared
The Invus Group, LLC4 shared
VIB4 shared
EQT Life Sciences3 shared
BioGeneration Ventures3 shared
Seroba Life Sciences3 shared
Last updated: 27 September 2026